Moleculin Biotech, Inc.
MBRX
$0.5628
-$0.012-2.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -30.32% | -54.14% | -81.83% | -61.74% | -66.29% |
| Total Receivables | -44.44% | -- | -79.80% | -- | -25.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -54.42% | -86.26% | -72.82% | -27.22% | 5.54% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -10.07% | -- | -39.27% | -- | -49.39% |
| Total Current Assets | -33.90% | -50.73% | -80.23% | -57.95% | -61.19% |
|
|
|||||
| Total Current Assets | -33.90% | -50.73% | -80.23% | -57.95% | -61.19% |
| Net Property, Plant & Equipment | -32.61% | -29.05% | -26.76% | -17.10% | 18.57% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -15.57% | -31.88% | -55.71% | -40.81% | -45.72% |
|
|
|||||
| Total Accounts Payable | 31.34% | 28.61% | -18.73% | 26.99% | -31.50% |
| Total Accrued Expenses | 45.09% | 27.26% | -23.90% | 63.34% | 15.84% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.29% | 13.76% | 20.00% | 31.82% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 37.71% | 27.51% | -21.36% | 43.85% | -12.33% |
|
|
|||||
| Total Current Liabilities | 37.71% | 27.51% | -21.36% | 43.85% | -12.33% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -30.48% | -27.56% | -24.47% | -21.37% | 44.33% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1,106.16% | 304.38% | 7.70% | 993,100.00% | 85,100.00% |
| Total Liabilities | 265.41% | 126.52% | -9.86% | 262.94% | 14.94% |
|
|
|||||
| Common Stock & APIC | 1.08% | 1.08% | 1.08% | 1.59% | 1.68% |
| Retained Earnings | -18.84% | -17.01% | -16.54% | -24.85% | -21.75% |
| Treasury Stock & Other | -280.00% | -111.11% | -355.56% | 233.33% | -242.86% |
| Total Common Equity | -140.47% | -99.81% | -77.07% | -78.72% | -56.03% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -140.47% | -99.81% | -77.07% | -78.72% | -56.03% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -140.47% | -99.81% | -77.07% | -78.72% | -56.03% |
|
|
|||||